Research Associate Neurology @ (August 2013 - October 2020)
Director of Preclinical Research, Translational Neuroscience Center @ (August 2013 - July 2017)
Assistant Professor Of Neurology @ (August 2016 - July 2017)
Instructor of Neurology @ (August 2013 - August 2016)
Director of Research @ (July 2012 - July 2013)
Associate Research Fellow, Neuroscience Research Unit, Pfizer Inc. @ (October 1999 - October 2011)
Post-doctoral Fellow @ (August 1993 - October 1999)
Robin Kleiman Education
University of Virginia
Ph.D. (Neuroscience)
1986-1993
University of Vermont
B.S. (Zoology)
1982-1986
Robin Kleiman Skills
Drug Discovery
Neuroscience
Molecular Biology
In Vitro
Translational Medicine
Clinical Development
Target Identification
Life Sciences
Pharmaceutical Industry
Drug Development
Cell
Biomarker Discovery
Signal Transduction
Laboratory
Cell Culture
Biotechnology
Genomics
Systems Biology
Assay Development
Pharmacology
Biochemistry
Clinical Trials
Lifesciences
Biomarkers
Stem Cells
Cell Biology
Electrophysiology
Protein Chemistry
Immunology
In Vivo
Clinical Research
Neurodegeneration
Translational Research
High Throughput Screening
Rare Diseases
Phosphodiesterases
Neurodevelopmental Disorders
Public Speaking
Validation
Data Analysis
PowerPoint
GPCRs
Animal Models
Robin Kleiman Summary
Robin Kleiman, based in Boston, MA, US, is currently a Chief Scientific Officer at Myrobalan Therapeutics. Robin Kleiman brings experience from previous roles at Alkermes, Biogen and Boston Children's Hospital. Robin Kleiman holds a 1986 - 1993 Ph.D. in Neuroscience @ University of Virginia. With a robust skill set that includes Drug Discovery, Neuroscience, Molecular Biology, In Vitro, Translational Medicine and more. Robin Kleiman has 4 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Robin Kleiman?
Find contact details for 700 million professionals.